Navigation Links
ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent

ence and technology, and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. These future events may not occur as and when expected, if at all, and, together with the Company's business, are subject to various risks and uncertainties. The Company's actual results could differ materially from expected results as a result of a number of factors, including the fact that preliminary results involved only a small number of test mice, the subsequent investigations were limited in scope, the uncertainties inherent in research and development collaborations, pre- clinical and clinical trials and product development programs, (including, but not limited to the fact that future results or research and development efforts may prove less encouraging than current results or cause side effects not observed in current pre-clinical trials) the evaluation of potential opportunities, the level of corporate expenditures and monies available for further studies, capital market conditions, and others set forth in the Company's periodic report on Form 10-QSB for the three months ended September 30, 2006 and on Form 10-KSB for the twelve months ended December 31, 2005 as filed with the Securities and Exchange Commission. There are no guarantees that any of the Company's proposed products will prove to be commercially successful. The Company undertakes no duty to update forward- looking statements. Contact:

     MEDIA CONTACT:

     W. Jason Grimley

     Spelling Communications

     310-477-9500

     


     INVESTOR CONTACT:

     Josh Reynolds

     CEOcast, Inc.

     212-732-4300

     


     IN-HOUSE INVESTOR CONTACT:
'"/>




Page: 1 2 3 4

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
6. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:7/29/2014)... YORK , July 29, 2014  Longtime industry ... Caremark Rx, Drew Crawford today announced the ... the leading independent media source dedicated to delivering fair, ... on the pharmacy benefit management (PBM) industry .  ... of, and context behind, industry news.   The outlet will ...
(Date:7/29/2014)... , July 29, 2014 McGraw-Hill Education Professional, ... the science, technical, and medical communities, has announced the ... off-line mobile application of the world-renowned medical education platform. ... AccessMedicine App , available for download onto all ... be able to gain access to valuable AccessMedicine ...
(Date:7/29/2014)... According to a new market ... Devices Market - Global Forecast, Market Share, Size, Growth ... trauma fixation devices market is estimated at USD 6.1 ... a CAGR of 7.2% from 2014 to 2019, to ... 2020. Browse the Orthopedic Trauma Fixation Devices ...
Breaking Medicine Technology:Drew Crawford Announces Launch of PBM365 Media 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4
(Date:7/29/2014)... Los Angeles, CA (PRWEB) July 29, 2014 ... on the website of Time Magazine titled “From Kim’s ... Want,” Kim Kardashian’s butt is the celebrity ... celebrities and their features include Beyoncé’s butt, Jennifer ... and lips. This information is based on data collected ...
(Date:7/29/2014)... (July 29, 2014) Using quality improvement measures in ... England Cardiovascular Disease Study Group, researchers have found a ... procedure with contrast dye. , Currently, 7-15 percent of ... contrast-dye end up with kidney injury, which can result ... to temporary or permanent dialysis, says a study published ...
(Date:7/29/2014)... Gainesville, FL (PRWEB) July 29, 2014 Many ... very first thing they do each morning is put on ... the bathroom. These same individuals also may be dissatisfied ... cataracts. , Cataracts may cause difficulty driving, especially ... harder to follow or find one’s golf ball, see the ...
(Date:7/29/2014)... New high priced hepatitis C drugs will increase ... $2.9 to $5.8 billion next year, according to a ... by the Pharmaceutical Care Management Association (PCMA). Milliman projects ... much as 8.6 percent in 2015 as a result ... , The study finds that the majority of new ...
(Date:7/29/2014)... Alan Mozes HealthDay ... Treating certain adult autism patients with just a single dose ... facial expressions and emotions, Japanese researchers report. Known as ... role in emotional bonding between lovers, and between mothers and ... activity in a key area of the brain that has ...
Breaking Medicine News(10 mins):Health News:Celebrity Plastic Surgery: Kim Kardashian’s Butt Tops the List of Celebrity Plastic Surgery Requests 2Health News:Reducing kidney injury using a quality improvement method 2Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3
... , , KENILWORTH, N.J., Aug. 6 ... live Webcast of its Special Shareholders Meeting being held on Friday, ... between Schering-Plough and Merck & Co., Inc. Originating from Boston, ... corporate Web site, www.schering-plough.com . , , ...
... exposure associated with skin inflammation in study of myositis ... ultraviolet (UV) rays may trigger certain types of autoimmune ... "This study found that women who lived in areas ... an autoimmune muscle disease called myositis were more likely ...
... ... Health Letter focuses on the feet and their common ailments. Dr. James Ioli, chief of podiatry ... ... of our feet. They provide a steady base when we stand, serve as shock absorbers when ...
... Aug. 6 Vitamin Shoppe Industries Inc., a leading specialty ... will hold a conference call for its bondholders on Thursday, ... call, members of management will report on the Company,s second ... To participate in the teleconference, bondholders are invited to call ...
... BEIJING and BETHESDA, Md., Aug. 6 /PRNewswire-Asia/ -- ... ("Chindex") (Nasdaq: CHDX ), a leading,independent ... in,the People,s Republic of China, today announced that ... plans to,launch a comprehensive, international-standard oncology program, called ...
... , , SAN DIEGO, Aug. 6 AMN Healthcare Services, Inc. (NYSE: AHS ) today announced ... 2009 include: , , ... % Chg % Chg, ... Q2 2009 Q2 2008 Q1 2009, ------------------------------------------------------------, ...
Cached Medicine News:Health News:Sunlight May Cause Rash in Autoimmune Disease 2Health News:Harvard Health Letter Special Section Features the Body's Unsung Marvels: The Feet 2Health News:Chindex International, Inc. Launches World-Class Cancer Treatment Center 2Health News:Chindex International, Inc. Launches World-Class Cancer Treatment Center 3Health News:Chindex International, Inc. Launches World-Class Cancer Treatment Center 4Health News:AMN Healthcare Announces Second Quarter 2009 Results 2Health News:AMN Healthcare Announces Second Quarter 2009 Results 3Health News:AMN Healthcare Announces Second Quarter 2009 Results 4Health News:AMN Healthcare Announces Second Quarter 2009 Results 5Health News:AMN Healthcare Announces Second Quarter 2009 Results 6Health News:AMN Healthcare Announces Second Quarter 2009 Results 7Health News:AMN Healthcare Announces Second Quarter 2009 Results 8Health News:AMN Healthcare Announces Second Quarter 2009 Results 9Health News:AMN Healthcare Announces Second Quarter 2009 Results 10Health News:AMN Healthcare Announces Second Quarter 2009 Results 11Health News:AMN Healthcare Announces Second Quarter 2009 Results 12Health News:AMN Healthcare Announces Second Quarter 2009 Results 13Health News:AMN Healthcare Announces Second Quarter 2009 Results 14Health News:AMN Healthcare Announces Second Quarter 2009 Results 15Health News:AMN Healthcare Announces Second Quarter 2009 Results 16
Blunt, fine curved shaft hook to unroll membranes. 24 gauge shaft with dark finish for reduced glare....
0.2 mm hook with curved shaft to reach over lens optic. Flat serrated handle with polished finish. Overall length: 4.8 inches. Most popular size or model....
Angled 45 degrees, 10 mm shaft with 0.2 mm tip. Round knurled handle with dull finish. Overall length: 4.6 inches....
Straight 31 mm shaft with flat handle and polished finish. 0.5 mm cup. Overall length: 5 inches....
Medicine Products: